Bibliography
- Brewer GJ, Askari FK. Wilson’s disease: clinical management and therapy. J Hepatol 2005;42(Suppl 1):S13-21
- Walshe JM. Penicillamine, a new oral therapy for Wilson’s disease. Am J Med 1956;21:487-95
- Walshe JM. Treatment of Wilson’s disease with trientine (triethylene tetramine) dihydrochloride. Lancet 1982;1:643-7
- Prasad AS, Brewer GJ, Schoomaker EB, Rabbini P. Hypocupremia induced by zinc therapy in adults. JAMA 1978;240:2166-8
- Brewer GJ, Hill GM, Prasad AS, et al. Oral zinc therapy for Wilson’s disease. Ann Intern Med 1983;99:314-19
- Schouwink G. De hepatocerebrale degeneratie, me een onderzoek naar de zinktofwisseling. MD thesis University of Amsterdam, Netherlands; 1961
- Brewer GJ, Dick RD, Johnson VD, et al. Treatment of Wilson’s disease with zinc: XV long-term follow-up studies. J Lab Clin Med 1998;132:264-78
- Brewer GJ, Terry CA, Aisen AM, Hill GM. Worsening of neurologic syndrome in patients with Wilson’s disease with initial penicillamine therapy. Arch Neurol 1987;44:490-3
- Brewer GJ, Hedera P, Kluin KJ, et al. Treatment of Wilson disease with ammonium tetrathiomolybdate: III. Initial therapy in a total of 55 neurologically affected patients and follow-up with zinc therapy. Arch Neurol 2003;60:379-85
- Brewer GJ, Askari F, Lorincz MT, et al. Treatment of Wilson disease with ammonium tetrathiomolybdate: IV. Comparison of tetrathiomolybdate and trientine in a double-blind study of treatment of the neurologic presentation of Wilson disease. Arch Neurol 2006;63:521-7
- Roberts EA, Schilsky ML; American Association for Study of Liver D. Diagnosis and treatment of Wilson disease: an update. Hepatology 2008;47:2089-111
- European Association for Study of L. EASL Clinical Practice Guidelines: wilson’s disease. J Hepatol 2012;56:671-85
- Weiss KH, Gotthardt DN, Klemm D, et al. Zinc monotherapy is not as effective as chelating agents in treatment of Wilson disease. Gastroenterology 2011;140:1189-98 e1
- Gunther P, Kuhn HJ, Herman W. Monitoring therapy in Wilson’s disease by the oral radiocopper test. Aktuelle Neurol 2013;40:195-9
- Brewer GJ, Yuzbasiyan-Gurkan V, Dick R. Zinc therapy of Wilson’s disease: VIII. Dose response studies. J Trace Elem Exp Med 1990;3:227-34
- Linn FH, Houwen RH, van Hattum J, et al. Long-term exclusive zinc monotherapy in symptomatic Wilson disease: experience in 17 patients. Hepatology 2009;50:1442-52
- Brewer GJ. Copper excess, zinc deficiency, and cognition loss in Alzheimer’s disease. Biofactors 2012;38:107-13